174 related articles for article (PubMed ID: 11900998)
1. Dynamic contrast-enhanced T2*-weighted MR imaging of gliomatosis cerebri.
Yang S; Wetzel S; Law M; Zagzag D; Cha S
AJNR Am J Neuroradiol; 2002 Mar; 23(3):350-5. PubMed ID: 11900998
[TBL] [Abstract][Full Text] [Related]
2. Fluid-attenuated inversion-recovery MR imaging of gliomatosis cerebri.
Essig M; Schlemmer HP; Tronnier V; Hawighorst H; Wirtz R; van Kaick G
Eur Radiol; 2001; 11(2):303-8. PubMed ID: 11218032
[TBL] [Abstract][Full Text] [Related]
3. Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging.
Knopp EA; Cha S; Johnson G; Mazumdar A; Golfinos JG; Zagzag D; Miller DC; Kelly PJ; Kricheff II
Radiology; 1999 Jun; 211(3):791-8. PubMed ID: 10352608
[TBL] [Abstract][Full Text] [Related]
4. Role of perfusion-weighted imaging at 3 Tesla in the assessment of malignancy of cerebral gliomas.
Di Costanzo A; Pollice S; Trojsi F; Giannatempo GM; Popolizio T; Canalis L; Armillotta M; Maggialetti A; Carriero A; Tedeschi G; Scarabino T
Radiol Med; 2008 Feb; 113(1):134-43. PubMed ID: 18338133
[TBL] [Abstract][Full Text] [Related]
5. Echo-planar MR determination of relative cerebral blood volume in human brain tumors: T1 versus T2 weighting.
Bruening R; Kwong KK; Vevea MJ; Hochberg FH; Cher L; Harsh GR; Niemi PT; Weisskoff RM; Rosen BR
AJNR Am J Neuroradiol; 1996 May; 17(5):831-40. PubMed ID: 8733954
[TBL] [Abstract][Full Text] [Related]
6. Value of diagnosis and differential diagnosis of MRI and MR spectroscopy in gliomatosis cerebri.
Yu A; Li K; Li H
Eur J Radiol; 2006 Aug; 59(2):216-21. PubMed ID: 16769190
[TBL] [Abstract][Full Text] [Related]
7. Gliomatosis cerebri: comparison of MR and CT features.
Shin YM; Chang KH; Han MH; Myung NH; Chi JG; Cha SH; Han MC
AJR Am J Roentgenol; 1993 Oct; 161(4):859-62. PubMed ID: 8372774
[TBL] [Abstract][Full Text] [Related]
8. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging.
Law M; Yang S; Wang H; Babb JS; Johnson G; Cha S; Knopp EA; Zagzag D
AJNR Am J Neuroradiol; 2003; 24(10):1989-98. PubMed ID: 14625221
[TBL] [Abstract][Full Text] [Related]
9. Clinical relevance of diffusion and perfusion magnetic resonance imaging in assessing intra-axial brain tumors.
Rollin N; Guyotat J; Streichenberger N; Honnorat J; Tran Minh VA; Cotton F
Neuroradiology; 2006 Mar; 48(3):150-9. PubMed ID: 16470375
[TBL] [Abstract][Full Text] [Related]
10. Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected].
Lev MH; Ozsunar Y; Henson JW; Rasheed AA; Barest GD; Harsh GR; Fitzek MM; Chiocca EA; Rabinov JD; Csavoy AN; Rosen BR; Hochberg FH; Schaefer PW; Gonzalez RG
AJNR Am J Neuroradiol; 2004 Feb; 25(2):214-21. PubMed ID: 14970020
[TBL] [Abstract][Full Text] [Related]
11. Three-dimensional dynamic susceptibility-weighted perfusion MR imaging at 3.0 T: feasibility and contrast agent dose.
Manka C; Träber F; Gieseke J; Schild HH; Kuhl CK
Radiology; 2005 Mar; 234(3):869-77. PubMed ID: 15665227
[TBL] [Abstract][Full Text] [Related]
12. Neuroimaging in pediatric brain tumors: Gd-DTPA-enhanced, hemodynamic, and diffusion MR imaging compared with MR spectroscopic imaging.
Tzika AA; Zarifi MK; Goumnerova L; Astrakas LG; Zurakowski D; Young-Poussaint T; Anthony DC; Scott RM; Black PM
AJNR Am J Neuroradiol; 2002 Feb; 23(2):322-33. PubMed ID: 11847064
[TBL] [Abstract][Full Text] [Related]
13. Blood volume of gliomas determined by double-echo dynamic perfusion-weighted MR imaging: a preliminary study.
Uematsu H; Maeda M; Sadato N; Matsuda T; Ishimori Y; Koshimoto Y; Kimura H; Yamada H; Kawamura Y; Yonekura Y; Itoh H
AJNR Am J Neuroradiol; 2001; 22(10):1915-9. PubMed ID: 11733325
[TBL] [Abstract][Full Text] [Related]
14. Multivoxel magnetic resonance spectroscopy in gliomatosis cerebri.
Uysal E; Erturk M; Yildirim H; Karatag O; Can M; Tanik C; Basak M
Acta Radiol; 2005 Oct; 46(6):621-4. PubMed ID: 16334845
[TBL] [Abstract][Full Text] [Related]
15. Dynamic contrast-enhanced T2*-weighted MR imaging of tumefactive demyelinating lesions.
Cha S; Pierce S; Knopp EA; Johnson G; Yang C; Ton A; Litt AW; Zagzag D
AJNR Am J Neuroradiol; 2001; 22(6):1109-16. PubMed ID: 11415906
[TBL] [Abstract][Full Text] [Related]
16. Brain abscess and cystic brain tumor: discrimination with dynamic susceptibility contrast perfusion-weighted MRI.
Erdogan C; Hakyemez B; Yildirim N; Parlak M
J Comput Assist Tomogr; 2005; 29(5):663-7. PubMed ID: 16163039
[TBL] [Abstract][Full Text] [Related]
17. Gliomatosis cerebri, imaging findings of 12 cases.
Desclée P; Rommel D; Hernalsteen D; Godfraind C; de Coene B; Cosnard G
J Neuroradiol; 2010 Jul; 37(3):148-58. PubMed ID: 20334921
[TBL] [Abstract][Full Text] [Related]
18. Comparison of dynamic susceptibility-weighted contrast-enhanced MR methods: recommendations for measuring relative cerebral blood volume in brain tumors.
Paulson ES; Schmainda KM
Radiology; 2008 Nov; 249(2):601-13. PubMed ID: 18780827
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a first-pass gradient-echo spin-echo method to predict brain tumor grade and angiogenesis.
Schmainda KM; Rand SD; Joseph AM; Lund R; Ward BD; Pathak AP; Ulmer JL; Badruddoja MA; Krouwer HG
AJNR Am J Neuroradiol; 2004 Oct; 25(9):1524-32. PubMed ID: 15502131
[TBL] [Abstract][Full Text] [Related]
20. Comparing perfusion metrics obtained from a single compartment versus pharmacokinetic modeling methods using dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade.
Law M; Young R; Babb J; Rad M; Sasaki T; Zagzag D; Johnson G
AJNR Am J Neuroradiol; 2006 Oct; 27(9):1975-82. PubMed ID: 17032878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
